CBDY · XBRL financial data

Target Group financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (CBDY's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	30	0	0	3,720	6,592	3,881
Cost of goods and services sold	25	—	0	2,065	2,866	1,813
Gross profit	5	—	0	1,655	3,725	2,068
General and administrative	136	—	—	—	—	—
Total operating expenses	1,569	1,350	1,240	2,086	2,609	2,290
Interest income	—	—	—	—	31	34
Interest expense	514	986	1,122	1,411	1,154	1,044
Income tax expense (benefit)	0	0	0	0	0	0
Net income (loss)	(7,074)	273	(4,520)	(324)	161	(1,360)
Earnings per share, basic USD per share	(0.01)	0.00	(0.01)	(0.00)	0.00	(0.00)
Earnings per share, diluted USD per share	(0.01)	0.00	(0.01)	(0.00)	0.00	(0.00)
Weighted average shares, basic thousands of shares	566,883	595,348	617,026	617,026	617,026	617,026
Weighted average shares, diluted thousands of shares	566,883	595,348	617,026	617,026	727,226	617,026

Fiscal years (CBDY's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	182	122	232	745	1,878	109
Accounts receivable	2	2	2	1,032	77	446
Inventory	99	99	0	1,216	882	1,669
Total current assets	755	584	910	3,094	3,102	2,330
Property and equipment, net	7,794	6,842	5,554	5,430	4,186	3,554
Right-of-use asset	101	85	63	47	38	33
Goodwill	3,666	3,682	263	269	248	260
Total assets	13,037	13,063	7,566	8,841	7,574	6,177
Current portion of long-term debt	1,031	602	1,737	7,880	7,244	7,604
Total current liabilities	4,873	4,043	6,927	14,589	13,096	13,382
Long-term debt	7,294	7,760	5,958	—	—	—
Lease liability, non-current	1,622	1,528	1,320	1,224	985	858
Total liabilities	16,557	15,215	14,125	15,814	14,081	14,240
Accumulated deficit	(26,536)	(26,264)	(30,784)	(31,107)	(30,947)	(32,307)
Total stockholders' equity	(3,521)	(2,152)	(6,560)	(6,973)	(6,508)	(8,063)
Total liabilities and equity	13,037	13,063	7,566	8,841	7,574	6,177
Common shares outstanding (cover page) thousands of shares	573,277	617,026	617,026	617,026	617,026	617,026

Fiscal years (CBDY's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(7,074)	273	(4,520)	(324)	161	(1,360)
Depreciation and amortization	293	972	—	—	—	—
Net cash from operating activities	(1,433)	100	(1,015)	(590)	2,163	(842)
Purchases of property and equipment	43	—	—	—	—	—
Net cash from investing activities	(976)	(1,406)	1,015	417	(179)	81
Net cash from financing activities	2,572	1,251	123	667	(730)	(1,065)

SIC 2833 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2833 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Target Group	14	1,381	(223)*	617.0M	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Creative Medical Technology Holdings	8,714	0	(1,472)*	6.6M	5.9 quarters	Q2 FY26 10-QJun 30, 2026
Soligenix	9,811	not reported	(1,707)*	21.8M	5.7 quarters	Q2 FY26 10-QJun 30, 2026
Aspira Women's Health	477	17	(2,010)*	46.6M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Matinas BioPharma Holdings	761	not reported	(1,836)*	14.7M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
Synlogic	13,183	0	(922)*	12.2M	14.3 quarters	Q2 FY26 10-QJun 30, 2026
Viskase Holdings	7,747	95,279	454*	14.3M	—	Q3 FY26 10-QSep 30, 2026
China Pharma Holdings	305	948	(33)*	43.0M	9.3 quarters	Q2 FY26 10-QJun 30, 2026
Xenetic Biosciences	6,472	661	(875)*	2.3M	7.4 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.